×
About 4,013 results

ALLMedicine™ Aortic Regurgitation Center

Research & Reviews  1,439 results

Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement ...
https://doi.org/10.1001/jama.2022.5776
JAMA , Toff WD et. al.

May 18th, 2022 - Transcatheter aortic valve implantation (TAVI) is a less invasive alternative to surgical aortic valve replacement and is the treatment of choice for patients at high operative risk. The role of TAVI in patients at lower risk is unclear. To determ...

Giant Subaortic Left Ventricular Diverticulum with Aortic Regurgitation and Stenosis.
https://doi.org/10.1093/icvts/ivac121
Interactive Cardiovascular and Thoracic Surgery; Hu R, Wang Z et. al.

May 17th, 2022 - Subaortic left ventricular diverticulum (SLVD) represents an extremely rare congenital anomaly, it could be asymptomatic but sometimes develop fatal complications. Treatment has been debated due to limited experience. We present successful treatme...

An Unusual Case of Left Ventricular Outflow Tract Obstruction after Aortic Valve Replac...
https://doi.org/10.1536/ihj.21-673
International Heart Journal; Hashimoto M, Kaneko M et. al.

May 16th, 2022 - Surgical valve replacement improves the symptoms and prognosis of patients with valvular heart diseases. Aortic regurgitation elicits volume overload that causes enlargement of the left ventricle (LV), while the LV size often shrinks to near norma...

Combined Cardiovascular Syphilis and Aortic Valve Stenosis (Due to a Congenitally Unicu...
https://doi.org/10.1016/j.amjcard.2022.02.020
The American Journal of Cardiology; Makhdumi M, Roberts WC

May 16th, 2022 - Described herein is a 53-year-old man who underwent resection of a fusiform aneurysm of the ascending aorta, and excision of a congenitally malformed stenotic unicuspid aortic valve. Examination of the wall of the aortic aneurysm disclosed classic...

see more →

Clinicaltrials.gov  15 results

Biomarkers in Aortic Stenosis - B.A.S.S.
https://clinicaltrials.gov/ct2/show/NCT01334801

May 5th, 2022 - Patients with aortic stenosis, hypertrophic cardiomyopathy, mitral regurgitation, aortic regurgitation, artificial heart valve regurgitation or stenosis, and tricuspid valve regurgitation associated with pacemaker leads who are referred for clinic...

Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI
https://clinicaltrials.gov/ct2/show/NCT04281771

Apr 29th, 2022 - INTRODUCTION AND RATIONALE Transcatheter aortic valve implantation (TAVI) has become the standard of care in elderly patients with severe symptomatic aortic valve stenosis and increased surgical risks due to advanced age and multiple comorbidity(2...

The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation
https://clinicaltrials.gov/ct2/show/NCT04217135

Jan 6th, 2022 - Background: The investigator team had focused on heart failure (HF) treatment for many years and tried to develop non-invasive guide for HF treatment. Initially, the investigators had dedicated to use echocardiography to simulate Swan-Ganz and per...

TAVI and Gender Outcomes Aortic Stenosis Undergoing Transfemoral Transcatheter Aortic Valve Implantation.
https://clinicaltrials.gov/ct2/show/NCT04915976

Jun 7th, 2021 - Severe aortic stenosis (AS) is the commonest form of valvular abnormality in the developed world and accounts for more than 40% of patients with native valvular disease with an approximately equal prevalence in males and females. Transcatheter aor...

Development of an Algorithm to Differentiate Heart Murmurs Using Electronic Stethoscopes
https://clinicaltrials.gov/ct2/show/NCT04400513

Mar 23rd, 2021 - Valvular heart disease (VHD), a subclass of structural heart disease (SHD), is a major cause of mortality and reduced quality of life for tens of millions of patients worldwide. Detecting VHD early allows the disease to be carefully monitored so t...

see more →

News  149 results

SURTAVI at 5 Years Reinforces TAVR but Was It Long-term Enough?
https://www.medscape.com/viewarticle/962484

Nov 8th, 2021 - The SURTAVI trial has become the second major face-off between transcatheter and surgical aortic valve replacement (TAVR and SAVR, respectively), after PARTNER 2A, to show parity in 5-year clinical outcomes in patients with severe, symptomatic aor...

Infective Endocarditis With Stroke After TAVR Has 'Dismal' Prognosis
https://www.medscape.com/viewarticle/950702

May 6th, 2021 - Patients who suffer a stroke during hospitalization for infective endocarditis (IE) after transcatheter aortic valve replacement (TAVR) have a dismal prognosis, with more than half dying during the index hospitalization and two thirds within the f...

MHRA Highlights Risk of Heart Valve Regurgitation with Fluoroquinolones
https://www.medscape.com/viewarticle/943287

Dec 29th, 2020 - The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update highlighting a small risk of heart valve regurgitation with the use of systemic and inhaled fluoroquinolones. The update follows a European review of ep...

New Valve Disease Guideline: Rethinking TAVR vs SAVR, MitraClip Indications
https://www.medpagetoday.com/cardiology/pci/90291

Dec 17th, 2020 - Transcatheter interventions get more love in updated valvular heart disease guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA). Patients with severe aortic stenosis who have choices for intervention shoul...

LV Volume May Work as Well as Linear Measures in Pinpointing Aortic Regurgitation Mortality Risk
https://www.medscape.com/viewarticle/940744

Nov 11th, 2020 - NEW YORK (Reuters Health) - In asymptomatic patients with chronic aortic regurgitation (AR), left ventricular end-systolic volume index (LVESVi) and volume-derived LV ejection fraction (Vol-LVEF) work as well as LV end-systolic dimension index (LV...

see more →

Patient Education  2 results see all →